A Dual Function Protein, ATIA, Is A Novel Diagnostic Marker For Human Glioblastoma And A Potential Therapeutic Target For Treating The Disease Read more about A Dual Function Protein, ATIA, Is A Novel Diagnostic Marker For Human Glioblastoma And A Potential Therapeutic Target For Treating The Disease US Application 61/182,072Filed on 2009-05-28
A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL) Read more about A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL) US Application 61/178,688Filed on 2009-05-15
Methods Of Preparing Lymphocytes That Express Interleukin-12 And Their Use In The Treatment Of Cancer Read more about Methods Of Preparing Lymphocytes That Express Interleukin-12 And Their Use In The Treatment Of Cancer US Application 61/174,046Filed on 2009-04-30
Mutation Of Critcal Lysines In The LAT Adapter Molecular Leads To Enhance T Cell Signalling Read more about Mutation Of Critcal Lysines In The LAT Adapter Molecular Leads To Enhance T Cell Signalling US Application 61/176,231Filed on 2009-05-07
Granulysin Immunotherapy Read more about Granulysin Immunotherapy US Application 61/250,601Filed on 2009-10-12
Novel Molecular Scaffolds Are Broad-spectrum Antibiotics Read more about Novel Molecular Scaffolds Are Broad-spectrum Antibiotics US Application 60/707,531Filed on 2005-08-12
The Discovery And Validation Of MDR1-inverse Agents Read more about The Discovery And Validation Of MDR1-inverse Agents US Application 61/182,511Filed on 2009-05-29
Polyphenol, Beta-Lactam, and Porphyrin Compounds as Inhibitors of TDP1 and Methods of Treating Disorders Read more about Polyphenol, Beta-Lactam, and Porphyrin Compounds as Inhibitors of TDP1 and Methods of Treating Disorders US Application 61/268,130Filed on 2009-06-08
INHIBITORS OF MRE11, RAD50 AND/OR NBS1 Read more about INHIBITORS OF MRE11, RAD50 AND/OR NBS1 US Application 61/203,377Filed on 2008-12-22
Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection Read more about Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection US Application 60/844,240Filed on 2006-09-13